Acute leukemia is the most prevalent pediatric cancer in developed countries, where it affects 30-45 per 1,000,000 children per year 1 . Childhood acute leukemias are heterogeneous with respect to their underlying cellular and molecular biology, acquired genetic abnormalities, and associated clinical responses to combination chemotherapy 2 . It is therefore suspected that acute myeloblastic leukemia and subtypes of B-or T-cell-precursor ALL may not share a common etiology 3 .
Dysregulated immune response to common infection may be a cause for childhood ALL, and epidemiological data are consistent with transplacental carcinogen exposure as a basis for infant leukemias associated with MLL gene fusion 3 , but the role of environmental carcinogenesis in childhood leukemia is currently undefined. However, it is probable that the risk of ALL from environmental exposure is influenced by genetic variation. Data from the Swedish family-cancer database lends support to a small familial risk of ALL 4, 5 , independent of the high concordance in monozygotic twins (which has a nongenetic, in utero explanation). Direct evidence for an inherited genetic predisposition to ALL (although rare, affecting o5% of ALL) is provided by the high risk associated with Bloom's syndrome, neurofibromatosis, ataxia telangiectasia and constitutional trisomy 21 (Down syndrome) 6 . The heritable basis of susceptibility to ALL outside these four syndromes is presently undefined, but it is likely that the co-inheritance of multiple low-risk variants contribute to disease risk. Predicated on this hypothesis, we conducted a genomewide association (GWA) study of ALL, analyzing two case series genotyped using Illumina Infinium HD Human370 Duo BeadChips.
The first GWA study (GWA-1) was based on genotyping 577 individuals with ALL (cases) from the United Kingdom Childhood Cancer Study (UKCCS) 7 . After application of quality control criteria and exclusion of individuals with a non-western European genotype, SNP genotype data were available for 503 of the cases ( Supplementary  Fig. 1 ). For controls, we used publicly accessible Illumina Hap550K BeadChip genotype data generated for 1,438 individuals from the British 1958 Birth Cohort (58C, also known as the National Child Development Study) 8 , which included all live births in England, Wales and Scotland during a single week in 1958.
The second GWA study (GWA-2) was based on genotyping 392 cases from the Medical Research Council (MRC) ALL 97 trial and 36 cases collected by the Northern Institute for Cancer Research (NICR). After application of quality control criteria and exclusion of individuals with non-western European genotype, SNP genotype data were available for 404 of the cases ( Supplementary Fig. 1 ). For controls, we used Illumina Hap550K BeadChip genotype data generated on 960 healthy individuals from the UK as part of a study of colorectal cancer 9 .
Across both case series, a total of 342,665 tagging SNPs were satisfactorily genotyped (99.7% of SNPs), with mean individual sample call rates (the percentage of samples for which a genotype was obtained for each SNP) of 99.8%. We excluded 24 individuals because of non-western European ancestry and 10 because of cryptic relatedness through examination of genotypes ( Supplementary  Fig. 2 ). Genotypes for 293,371 SNPs were available for all 907 cases (824 B-cell ALL, 83 T-cell ALL) and 2,398 controls in the combined data ( Supplementary Fig. 1 ). Before undertaking a meta-analysis, we searched for potential errors and biases in the two GWA studies, imposing a high stringency for quality control for SNPs. Specifically, we considered only the 291,473 autosomal SNPs that had call rates 495% in all case and control series, that showed no extreme departure from Hardy-Weinberg equilibrium (HWE; P 4 10 À5 in controls) and that had minor allele frequencies exceeding 1% in cases and controls ( Supplementary Fig. 1) .
Comparison of the observed and expected distributions showed little evidence for an inflation of the test statistics in the two datasets (inflation factor 10 l ¼ 1.034 and 1.002 for GWA-1 and GWA-2, respectively, based on the 90% least significant SNPs; Supplementary  Fig. 3 ), thereby excluding the possibility of significant hidden population substructure or differential genotype calling between cases and controls. Using data from both GWA studies, we derived joint ORs and confidence intervals (CI) under a fixed-effects model for each SNP and associated P values from the standard normal distribution.
Ten SNPs mapping to three genomic regions showed evidence of an association at the conventional level for genome-wide significance of P o 5.0 Â 10 -7 (ref. 11). These associations were significant at this threshold regardless of which control group was used for reference (Supplementary Table 1 ).
The strongest association signal was attained at 7p12.2 with rs4132601 (combined OR ¼ 1.69, 95% CI 1.58-1.81, P ¼ 1.20 Â 10 -19 , P het ¼ 0.68, I 2 ¼ 0%; Table 1 and Supplementary Table 1) , which maps to the 3¢ region of the Ikaros family zinc finger 1 (IKZF1) gene (50,438,098 bp; Fig. 1 ). The association signal was also highly significant when analysis was confined to B-cell ALL (combined OR ¼ 1.73, 95% CI 1.61-1.85, P ¼ 9.31 Â 10 -20 ; Table 1 and Supplementary Table 1 ). rs6944602 and rs6964823, which map to the 3¢ UTR and intron 7 of IKZF1 (50,441,245 bp and 50,427,590 bp; Fig. 1 and Supplementary Fig. 4 ), also showed statistical support for an association at 7p12.2 at genome-wide threshold (P ¼ 6.02 Â 10 -14 and 3.43 Â 10 À15 , respectively). rs4132601, rs6964823 and rs6944602 map to a 27.3-kb block of linkage disequilibrium (LD). LD metrics for rs4132601-rs6964823, rs4132601-rs6944602 and rs6964823-rs6944602 are D¢ ¼ 1.0, 1.0, 1.0 and r 2 ¼ 0.42, 0.79, 0.33, respectively. A significant association was also seen with rs7809758, which maps 110 kb centromeric to rs4132601 (50,540,827 bp, P ¼ 2.41 Â 10 -10 ) within the gene DDC, which encodes Dopa decarboxylase aromatic L-amino acid. LD between rs7809758 and rs4132601 is not strong (D¢ ¼ 0.72, r 2 ¼ 0.32), and the nine-order-of-magnitude difference in statistical support for the association with ALL defined by rs7809758 compared with rs4132601 argues against an independent disease locus. However, to confirm this will require further mapping of the region.
Although rs4132601 may not be directly functional, the established role of IKZF1 in the biology of ALL strongly implicates variation in IKZF1 as the causal basis of the 7p12.2 association. Ikaros proteins are master regulators of lymphocyte development, and differentiation plays a pivotal role in CD4 compared to CD8 T-cell lineage commitment decisions 12 . Germline mutant mice expressing only non-DNA binding dominant-negative leukemogenic Ikaros isoforms develop an aggressive form of lymphoblastic leukemia 13, 14 . Chromosomal deletions involving IKZF1 are common (30%) in high-risk/ poor prognosis B-cell precursor ALL 15 and are highly prevalent (95%) in ALL with BCR-ABL1 fusions 16 .
To explore the possibility that the association might be mediated through differential IKZF1 expression, we investigated the relationship between rs4132601 genotype and mRNA expression level in Epstein-Barr virus-transformed lymphocytes. mRNA expression was significantly associated with genotype in a dose-dependent fashion (P ¼ 0.005; Fig. 2 and Supplementary Fig. 5 The second-strongest association signal was attained at 10q21.2 with rs7089424 (combined OR ¼ 1.65, 95% CI 1.54-1.76, P ¼ 6.69 Â 10 -19 , P het ¼ 0.29, I 2 ¼ 7%; Table 1 and Supplementary  Table 1 ), which maps to intron 3 of the gene ARID5B, encoding AT-rich interactive domain 5B (63,422,165 bp; Fig. 1 and Supplementary Fig. 4 ). The association signal was also highly significant when analysis was confined to B-cell ALL (combined OR ¼ 1.70, 95% CI 1.58-1.81, P ¼ 1.41 Â 10 -19 ; Table 1 and Supplementary   Table 1 ). Two additional SNPs (rs7073837 and rs10740055) with among the most significant P values (P ¼ 4.66 Â 10 -16 and 5.35 Â 10 -13 , respectively) also annotate ARID5B (63,369,901 bp and 63,388,485 bp), localizing to introns 2 and 3 of the gene, respectively. These are in LD with rs7089424 (D¢ ¼ 0.89, 1.0 and r 2 ¼ 0.60, 0.43, respectively) and map to a 79.3-kb block of LD within ARID5B. ARID5B is member of the AT-rich interaction domain family of transcription factors 17 that plays an important role in embryogenesis and growth regulation 18 . Although ARID5B expression is reported to be upregulated in acute promyelocytic leukemia 19 , there is currently no evidence for involvement of ARID5B in childhood ALL. Evidence that ARID5B has a role in defining B-cell lineage is supported by data from homozygous knockout mice that, along with growth retardation phenotype, have decreased bone marrow cellularity and reduced numbers of B-cell progenitors 18 . The third-strongest statistical evidence for an association was attained at 14q11.2 with rs2239633 (22,658,897 bp; combined OR ¼ 1.34, 95% CI 1.22-1.45, P ¼ 2.88 Â 10 À7 , P het ¼ 0.22, I 2 ¼ 33%; Table 1 and Supplementary Table 1 ). As with the regions previously examined, this association signal was also significant when analysis was confined to B-cell ALL (combined OR ¼ 1.37, 95% CI 1.26-1.49, P ¼ 5.60 Â 10 -8 ; Table 1 and Supplementary  Table 1 ). rs2239633 maps within a 25.7-kb region of LD that encompasses the gene CEBPE, encoding CCAAT/enhancerbinding protein, epsilon ( Fig. 1 and Supplementary Fig. 4) . Two other SNPs associated with ALL risk at P o 10 -5 (rs7157021 and rs10143875) map within this region of LD, providing additional support for 14q11.2 as a susceptibility locus. C/EBP is a suppressor of myeloid leukemogenesis and is mutated in a subset of cases. Notably, CEBPE, along with other CEBP family members, has been shown to be occasionally (B1%) targeted by recurrent immunoglobulin heavy chain (IGH) translocations in B-cell precursor ALL 20 , suggesting opposing functions of C/EBP dysregulation in myeloid and lymphoid leukemogenesis and a possible role in susceptibility to ALL.
Given the biological heterogeneity of ALL, we analyzed the association between the major subtypes of ALL and rs4132601, rs7089424 and rs2239633 genotypes through case-only logistic regression ( Table 2 ). The primary impact of variation defined by the 7p12.2, 10q21.2 and 14q11.2 risk variants is for B-lineage leukemia. Subtype analysis of B precursor ALL provides strong evidence that variation at 10q21.2-ARID5B is highly associated with the risk of developing hyperdiploid ALL (P ¼ 3.84 Â 10 -6 ; Table 2 ).
Fine-mapping and resequencing is required to identify the specific functional variant underlying each of the associations we identified. Accepting that HapMap is not comprehensive, few nonsynonymous SNPs have been documented in IKZF1, ARID5B and CEBPE and none are correlated with rs4132601, rs7089424 or rs2239633. These data suggest that the associations we identified are mediated through LD with sequence changes that influence gene expression rather than protein sequence or through LD with low-frequency variants that are not catalogued by HapMap. Although we did not find a significant relationship between genotypes and ARID5B and CEBPE expression ( Supplementary Fig. 5 ), we were able to demonstrate a relationship between rs4132601 genotype and IKZF1 expression compatible with the causal variant at this locus influencing differential expression.
When we modeled pairwise combinations of the SNPs, we did not find evidence of interactive effects among any of the three loci identified (P 4 0.1 for all pairwise interactions; Supplementary  Table 2 ), suggesting that each locus has an independent role in ALL development. Although the risks of ALL associated with 7p12.2, 10q21.2 and 14q11.2 variants are modest, the carrier frequencies of risk alleles of rs4132601, rs7089424 and rs2239633 are high in the European population; hence the loci make a significant contribution to the development of ALL, underlying B64% of cases.
Our findings provide the first unambiguous evidence that common genetic variation influences the risk of developing pediatric ALL and a strong rationale for searching for additional risk variants through further GWA scans. These findings also provide new insight into the development of ALL. It is noteworthy that the three risk variants we identify map to genes involved in transcriptional regulation and differentiation of B-cell progenitors. Ethnic differences in the risk of ALL are well recognized 1 ; therefore, it will be interesting to explore how our findings translate to non-western European populations.
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